chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022 at 10:26 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022 at 10:26 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had received the vaccine dose number as second booster. No concomitant medications were reported. It was reported that a series of an approximately 540 patients had received lot number of 066H21A in past and had an its 30 days of an expiry date. The vaccine was administered up until its manufactured expiry date of 04-Apr-2022 and this lot number was no longer possessed. No treatment medications were reported.   This case was linked to MOD-2022-542869 (Patient Link).
Surrounding erythema about 10cm with streaking into axilla, subjective fever x 1 day, multiple (30-40) small papules (about 1-3 mm diam each), whitish in color (containing pus) surrounding vaccine site, but not touching it, 4 purulent papules on upper forehead (likely auto inoculation), treated with IV Ancef and Clindamycin x 24 hours, then oral Keflex and clindamycin x 10 days.
very dark discoloration appeared at the injection site; painful to touch; Feeling of warmth; Swollen arm; Nauseous; Vomited; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (very dark discoloration appeared at the injection site), FEELING HOT (Feeling of warmth), PERIPHERAL SWELLING (Swollen arm), NAUSEA (Nauseous) and VOMITING (Vomited) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027a21a and 031L20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shoulder replacement. Concurrent medical conditions included Drug allergy (Sulfa).   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced FEELING HOT (Feeling of warmth), PERIPHERAL SWELLING (Swollen arm), NAUSEA (Nauseous), VOMITING (Vomited) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (very dark discoloration appeared at the injection site) and VACCINATION SITE PAIN (painful to touch). The patient was treated with Manual therapy (Ice) for Peripheral swelling. At the time of the report, VACCINATION SITE DISCOLOURATION (very dark discoloration appeared at the injection site) was resolving and FEELING HOT (Feeling of warmth), PERIPHERAL SWELLING (Swollen arm), NAUSEA (Nauseous), VOMITING (Vomited), CHILLS (Chills) and VACCINATION SITE PAIN (painful to touch) outcome was unknown.            Treatment information included Tylenol. Ice   This case was linked to MOD-2021-034896 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up TCR received on 30-Apr-2021. Added events and events outcome.
I tested positive for COVID-19 on 11/28/22. I had congestion, sore throat, diarrhea, headache, and fatigue. I was tired I had to take a nap every afternoon for about 2 hours. I contacted my doctor, and they offered to give me PAXLOVID, but I opted out of that. I am feeling better now.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No information on medical history, concurrent conditions or concomitant drugs was provided. On 19-NOV-2014 the patient was vaccinated with a dose of ROTATEQ vial (dose number, lot# and expiration date unknown), administered orally that underwent a supported temperature excursion. No adverse experience reported. Additional information has been requested.
Long term fever since October 18th. Averaging over 100 degrees.; Constant chills; Extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2590) via an unspecified route of administration in the left arm on 18Oct2021 at 17:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included living kidney donor and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously received clindamycin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. On 18Oct2021 at 19:00, the patient experienced long term fever averaging over 100 degrees, constant chills and extreme fatigue. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 03Nov2021, the patient underwent SARS-CoV-2 test via nasal swab and the result was negative. The clinical outcome of the events long term fever averaging over 100 degrees, constant chills and extreme fatigue were not resolved at the time of this report.
Once I sat down about 4 minutes after the shot my heart started racing very rapidly.  I became very light headed and my face was flushed.  It took about 10 minutes of trying to force myself from panicking ( I do not get panic attacks).  There were too many other people in the waiting room so I didn't feel like I could discretely tell the nurse about my reaction.  I felt light headed the rest of the day.  About 5 days later, I was sitting in the chair at my salon and it happened again.  Racing heart rate and all the same cardiac symptoms as before.  I do not have high blood pressure or any cardiac illness. I also had a heaviness, congested feeling in my chest for about 2 weeks.  I had another issue with very rapid heart rate for most of the day over the last two days.
A non-serious, spontaneous report of inflammation of the face iwth swelling and itching was received from a nurse, concerning an eight year-old male patient, subsequent to FLUMIST. The patient was not taking any concomitant medications. The patient has no known allergies or history of hypersensitivity. The patient received FLUMIST, nasal on 22-Oct-2008 for flu vaccinations. Twelve hours after administration of FLUMIST, the child experienced inflammation of the face with swelling and itching. There was no report of difficulty breathing or swelling of the tongue or throat. The nurse advised the parent to administer the patient diphenhydramine by mouth. The symptoms were ongoing at time of reporting on 24-Oct-2008 The outcome of the events is unknown.
Felt crippled unable to walk excruciating pain (bone next to tailbone on left side) Shortness of breath Couldn't hold urine  Felt perfectly fine until the morning of 3/20/21 (lasted 2 weeks-until I begged DR. to provide anti-inflammatory, 5% lidocaine patch  to treat this, and I did not want continue to take my Percocet (from previous facture event) that the Dr. recommended.
Patient experienced dizziness about 10 minutes after receiving the HPV (Gardasil) vaccine. The patient hit her head.
LEFT ARM SORE; NAUSEOUS; HEADACHE; TIREDNESS; DIZZINESS; This spontaneous report received from a patient concerned a 19 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included iron deficient. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203AZIA, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced dizziness. On 10-APR-2021, the subject experienced tiredness. On 10-APR-2021, the subject experienced headache. On 12-APR-2021, the subject experienced left arm sore. On 12-APR-2021, the subject experienced nauseous. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tiredness, and headache, was recovering from dizziness, and had not recovered from left arm sore, and nauseous. This report was non-serious.
Starting on the AM of 8/8/17 patient experienced myalgia in the neck radiating into the left scapula region. Started to decrease in severity, however on 8/10/17 developed hives bilaterally in the deltoid region, left deltoid region greater than the right.
Appendicitis; Stomach pain; This is a spontaneous report from a contactable consumer (patient). A 35-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9264), via an unspecified route of administration, in left arm on 06Feb2021 21:00 (at the age of 35-years-old) as dose 2, single for covid-19 immunization. Medical history included common cold. Patient had no known allergies. The patient's concomitant medications were not reported. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ELQ142), via an unspecified route of administration, in left arm on 12Jan2021 11:00 as DOSE 1, SINGLE for covid-19 immunization. On 25Feb2021 16:00, the patient experienced appendicitis, stomach pain (04:00). Eventually went to the ER and it was confirmed via CT Scan that patient had an appendicitis. It was treated with antibiotics because surgery at the time was not safe. The doctor decided that her appendix needed to be removed. She never had any illness before that required any type of hosp. The most severe thing she get was a common cold, so this was unexpected. Facility where the most recent COVID-19 vaccine was administered was other. The patient was hospitalized for appendicitis, stomach pain for 5 days. The patient underwent lab tests and procedures which included CT Scan resulted that she had an appendicitis on 25Feb2021. Therapeutic measures were taken as a result of appendicitis, stomach pain. Events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Patient received treatment with Antibiotics via IV and insertion of Line for events. The outcome of events were recovering.  Follow-up attempts are completed. No further information is expected.
chills; tiredness; achiness; flu like symptoms; Pain during the injection; This case was reported by a consumer via call center representative and described the occurrence of chills in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd January 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 22nd January 2020, immediately after receiving Shingrix, the patient experienced injection site pain. On 23rd January 2020, the patient experienced chills, tiredness, pain and influenza-like symptoms. On an unknown date, the outcome of the chills, tiredness, pain and influenza-like symptoms were recovering/resolving and the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the chills, tiredness, pain, influenza-like symptoms and injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 71 or 72 years. The patient received the dose of Shingrix and experiencing chills, tiredness and flu-like symptoms also experienced pain during the injection. The follow up consent was not granted. This case has been linked with case US2020013021, reported by same reporter.
Had shingles three times...even after the shot/Suspected vaccination failure; Had shingles three times...even after the shot; Best thing for pain is lidocaine patch; This case was reported by a consumer via media and described the occurrence of Suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. The patient was treated with lidocaine (Lidocaine Patch). On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient itself. The age at vaccination was not reported. Even after receiving Shingles vaccine, the had Shingles three time. The patient stated that best thing for pain was lidocaine patch for immediate relief. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, laboratory confirmation, time to onset of shingles were unknown at the time of reporting.
First vaccine, immediate side effect: felt lost, confused and had trouble driving home. Mild body aches for 2 days that came and went. Arm was sore and unable to move for 3 whole days starting immediately after shot. Second vaccine: felt great for about 12 hours after. No side effects at all. Ran errands and all. Next morning at 6 am, woke up with extreme body aches, fever, pain, headache, light sensitivity, can't keep any food down, vomiting, nausea upon standing and my left arm is so incredibly sore I can't even touch it. About 24 hours after second dose, I still feel the same symptoms. Awful pain all over (from toes to groin to shoulders) and a bad tension headache that won't go away, even with Tylenol.
Patient work up the morning after receiving the vaccine (morning of 8/23/19) with redness and swelling in his Right Arm about 5 cm in diameter around the vaccine site. The area was firm and hot to the touch and painful upon palpating. We administered Benadryl, to no noticeable effect. By the morning of 8/24, the affected area had spread to about 11 cm  (at this point, we outlined the affected area in order to monitor its progress), the area was still firm and hot to the touch and painful upon palpating. By the afternoon of 8/25/2019 the area had spread to about 14 cm with the same presentation. Patient was able to perform normal day-to-day activities with no impairment and showed no signs of fever of other adverse reaction. The area was treated with ice (8/23 & 8/24) and then gentle heat (8/25 through present). As of the morning of 8/26/2019 the area is showing some improvement, most noticeable around the perimeter. The initial affected area is still hot to the touch, but pain upon palpating is decreased and the skin is not as tight.
Pain at injection site, full body aches, headache, extreme fatigue, foggy cognition - all starting on 3/2/2021 at 5pm and lasting through 7am on 3/4/2021. Worst symptoms night of 3/2 and during day on 3/3.
V-trac representive called me and told me to report on here.  I have had a significant increase in migraine headache, 2-4 x month since my first vaccine.  I have a history of chronic headache but it has gotten much worse since December.   My second dose was on Jan 7, 2021 lot number EL0142.  I did receive a booster shot on 8/23/2021 lot # EW0187
severe pain and stiffness of neck, back and back of head - severe pain, hard to hold up got shot, walked away holding onto to shopping cart 5 minutes later I could hardly walk back to where I received shot held onto a shopping cart. Dr who gave shot gave me another shot - told to sit & wait
Pt recvd 3 doses of Engerix-B on 4DEC89, 21JAN90, & 28JUN90 & was found to be a non-responder;
HA severe chills shoulder pain nausea fever swelling Tx- Tramadol, ice Tylenol, Advil, Cymbalta
following #2 DTP pt was unconsolable for 3 hrs, sl elevated temp;
11:45am pt. stated "I feel dizzy".  vital signs taken BP 124/80, HR 78, O2Sat 99%, R 16,  11:50am pt. reported feeling better, he stated "I feel less dizzy now."  At 11:54am pt. stated, "dizziness is going away, I want to go home."  At 11:56 pt. went home.
Severe Joint pain, swelling, loss of left shoulder range of motion with impingement. Has not resolved even with therapy.
Baby woke up with a red rash, some partly raised, covering approx. 80-85% of his torso and back. Some of it extended onto his buttocks, neck, and ears, but none on his face, lower legs, or arms. He was vaccinated in the arm. Baby did NOT exhibit any signs of breathing difficulty or discomfort with the rash; that is, he was not scratching or itching. He went to sleep the night prior at about 7:30 PM. He did not have any signs of the rash at that time. He awoke at approx 7:00 AM on Friday morning, and when I undressed him from his pajamas, that is when I discovered the rash.
EXPERIENCED SOME ADVERSE EVENTS; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported.  On an unspecified date, the subject experienced experienced some adverse events. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of experienced some adverse events was not reported. This report was non-serious.
Headache, Fever, Pain in arm site: chills; body aches;  Narrative:
Reported 6 hours after received flu shot had pretty intense myalgia. This was relieved: motrin and a night's rest. On 11/21/05 Patient wondered if it was possible to develop herpes zoster without blisters. She was diagnosed with this after seeing her MD for right hip pain. I called CDC NIP hotline and informed no known correlation between flu shot and development og herpes zosters. I left a message on the CDC hotline and never got a call back. I called VAERS and only got a recording. I would have like to have beneficial to speak to someone from VAERS to see if completion of this form was necessary.
Fever of 102, fussy but no rash or other Sxs. Had GI Sxs after Rotavirus vaccine - so #2 was not given on this day.
TOOK TWO DOSES IN A ROW; This spontaneous case (PVX2019-866) was received from a consumer on 11-Apr-2019. It describes a 38-year-old male consumer who "took two doses in a row", while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.   Case report: The consumer took Vivotif doses in an inappropriate way. The doses were taken on day 1, 3, and day 4 (11-Apr-2019).  Action taken with Vivotif was not applicable.   The clinical outcome of the event "took two doses in a row" was unknown.  Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses in a row" was considered as not applicable.
doesn't have full function of left shoulder; nerve entrapment from the incorrect administration; The person who injected the vaccine into the joint space and not the deltoid; This is a spontaneous report from a contactable healthcare professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient stated she received the first dose of the vaccine on 21Dec and the person who injected the vaccine into the joint space and not the deltoid. The patient stated that she doesn't have full function of left shoulder because of nerve entrapment from the incorrect administration and asked if she is able to get the other dose somewhere other than her deltoid muscle. Clinical outcome of the events was unknown.  Information on lot/batch has been requested.
Bronchospasm/wheezing developed several hours after taking 1st and only dose of oral Typhoid. Didn't seek medication because does not have insurance. Treated with OTC Primatine Mist.
This spontaneous report as received from a physician assistant refers to a 36 year old female patient. On an unknown date, (also reported as "in her twenties") the patient was vaccinated with VARIVAX (Merck) both doses for chicken pox prevention. The physician stated that the on unspecified date, patient had her blood drawn recently and "titer for varicella came back negative". The physician stated that the patient was seeking to be pregnant and was advised to have titer drawn. The outcome of titer for varicella come back negative was unknown. This is one of several reports from the same source. Additional information has been requested.
Arm pain; Injection site pain; Fever; Chills; Nausea; Headache; Body aches; General malaise; This is a spontaneous report from a contactable nurse, the patient. This 49-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL9231 ),  dose  2 , single dose via an unspecified route of administration in the left arm on 07Jan2021 at 07:30 AM (at the age of 49 years-old) for COVID-19 vaccination.  Relevant medical history included high cholesterol. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL0140,), single dose, dose 1 in the left arm on 18Dec2020 at 09:30 AM. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included aspirin, rosuvastatin (CRESTOR), D3, zinc and multivitamin.  The patient did not receive  any other vaccine within 4 weeks prior to the vaccine. On 07Jan2021 at 10:00 PM, the patient experienced arm pain, injection site pain, fever, chills, nausea, headache, body aches and general malaise. The report was reported as non-serious. The patient was not treated for arm pain, injection site pain, fever, chills, nausea, headache, body aches and general malaise. The clinical outcome of arm pain, injection site pain, fever, chills, nausea, headache, body aches and general malaise was recovering.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.